appengine.ai

Artificial Intelligence | Machine Learning Insilico Medicine | Drug Discovery & Development


Enterprise, Health Care, Pharmaceutical & Medical Products, Drug Discovery, Digital Medicine Pak Shek Kok,, Hong Kong

Insilico Medicine

Artificial Intelligence | Machine Learning


Insilico Medicine | Drug Discovery & Development

Insilico Medicine

Health Care, Pharmaceutical & Medical Products, Drug Discovery, Digital Medicine


Pak Shek Kok,, Hong Kong

Insilico Medicine, Inc is an artificial intelligence company headquartered in Rockville, with R&D and management resources in Belgium, Russia, UK, Taiwan, and Korea sourced through hackathons and competitions. The company and its scientists are dedicated to extending human productive longevity and transforming every step of the drug discovery and drug development process through excellence in biomarker discovery, drug development, digital medicine, and aging research. Insilico pioneered the applications of generative adversarial networks (GANs) and reinforcement learning for the generation of novel molecular structures for diseases with a known target and with no known targets.

In addition to working collaborations with large pharmaceutical companies, the company is pursuing internal drug discovery programs in cancer, dermatological diseases, fibrosis, Parkinson's Disease, Alzheimer's Disease, ALS, diabetes, sarcopenia, and aging.

 

B2B

51 to 100

Series C

$306.3 M

Scaling Up

2014

 
 

Pharmaceuticals and Medical Products
Healthcare
Health Care Facilities & Hospitals

N/A

N/A

 
 

Production

Yes

Active

 
 

   Machine Learning


Deep Reinforcement

Deep Reinforcement

Drug Discovery

Drug Discovery


N/A

 

   Software


N/A


Machine Learning Algorithm

Machine Learning Algorithm

 
 

View All

View All AI/ML Jobs

Machine Learning Engineer

Shanghai , Pudong

Machine Learning Research Scientist

Shanghai , Pudong

Business Development Consultant

Remote, Remote

Sales Development Representative

Shanghai , Pudong

In vitro Scientist

Shanghai , Pudong

 
 

19

1

$255 M

Company was founded 2014 and it took almost 7 years (Jun 2021) to raise first external round

 
 

Date

Round

$ Raised

Investors

06/22/2021

Series C

$255 M

Warburg Pincus, Qiming Venture Partners, Pavilion Capital, Eight Roads Ventures, Lilly Asia Ventures, Sinovation Ventures, BOLD Capital Partners, Formic Ventures, Baidu Ventures, CPE, Mirae Asset Capital, OrbiMed, B Capital Group, Deerfield Management, Maison Capital, Lake Bleu Capital, President International Development Corporation, Sequoia Capital China, Sage Partners

Date : 06/22/2021

Round: Series C

$ Raised: $255 M

Investors: Warburg Pincus, Qiming Venture Partners, Pavilion Capital, Eight Roads Ventures, Lilly Asia Ventures, Sinovation Ventures, BOLD Capital Partners, Formic Ventures, Baidu Ventures, CPE, Mirae Asset Capital, OrbiMed, B Capital Group, Deerfield Management, Maison Capital, Lake Bleu Capital, President International Development Corporation, Sequoia Capital China, Sage Partners

 
 
Qingsong Zhu


Qingsong Zhu
COO

Alex (???? ?????) Zhavoronkov


Alex (???? ?????) Zhavoronkov
Founder and CEO

Alex Zhebrak


Alex Zhebrak
CTO

Feng Ren


Feng Ren
CSO